The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs
- 29 August 2002
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 23 (6) , 217-225
- https://doi.org/10.1002/bdd.315
Abstract
Objective—The purpose of this study was to determine the oral bioavailability and pharmacokinetics of a glucosamine (GL) and the disaccharides of chondroitin sulfate (CS) after single and multiple‐dosing of a GL/CS combination (CosaminR*, CosequinR*).Methods—Male beagle dogs (n= 8, 12 kg) received the following treatments: (1) IV GL (500 mg)/CS (400 mg), (2) p.o. GL (1500 mg)/CS (1200 mg), (3) p.o. GL (2000 mg)/CS (1600 mg), (4) p.o. GL (1500 mg)/CS (1200 mg) QD for days 1–7 and p.o. GL (3000 mg)/CS (2400 mg) from days 8 to 14. Blood samples were collected over 24 h and glucosamine and the disaccharides of chondroitin sulfate were determined. Pharmacokinetic analysis was performed on glucosamine and total chondroitin sulfate disaccharides and parameters were compared across treatments using ANOVA with post hoc analysis.Result—After the IV administration, glucosamine declined rapidly in a bi‐exponential fashion with a mean ( ± S.D.) eliminationt1/2of 0.52 (0.25) h. GL absorption was relatively fast (Cmax= 8.95 μg/ml, andTmax1.5 h after 1500 mg dose) and the mean bioavailability of glucosamine after single dosing was approximately 12%. The extent of absorption of chondroitin sulfate as indicated by the meanCmax(21.5 μg/ml) and mean AUC (187 μg/ml h) of total disaccharides after dosing (1600 mg) provides evidence that chondroitin sulfate is absorbed orally. The bioavailability of CS ranged from 4.8 to 5.0% after single dosing and 200–278% upon multiple dosing.Conclusion—The results of this study show that both glucosamine and chondroitin sulfate (measured as total disaccharides) are bioavailable after oral dosing. In addition, the low molecular weight chondroitin sulfate used in this study displays significant accumulation upon multiple dosing. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 16 references indexed in Scilit:
- PB35 Glucosam1ne HCL and chondroitin sulfate inhibit the catabolic response of articular caritlage explants cultured with lipopolysaccharideOsteoarthritis and Cartilage, 2001
- Effects of an orally administered mixture of chondroitin sulfate, glucosamine hydrochloride and manganese ascorbate on synovial fluid chondroitin sulfate 3B3 and 7D4 epitope in a canine cruciate ligament transection model of osteoarthritisOsteoarthritis and Cartilage, 2001
- Efficacy of Glucosamine and Chondroitin for Treatment of OsteoarthritisPublished by American Medical Association (AMA) ,2000
- Efficacy of a combination of FCHG49™ glucosamine hydrochloride, TRH122™ low molecular weight sodium chondroitin sulfate and manganese ascorbate* in the management of knee osteoarthritisOsteoarthritis and Cartilage, 2000
- Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1999
- The effect of nonsteroidal antiinflammatory drugs on human articular cartilage glycosaminoglycan synthesisOsteoarthritis and Cartilage, 1999
- Effects of chondroitin sulfate and interleukin-1β on human articular chondrocytes cultivated in clustersOsteoarthritis and Cartilage, 1998
- Determination of chondroitin sulphates in human whole blood, plasma and blood cells by high‐performance liquid chromatographyBiomedical Chromatography, 1995
- “Fast moving” and “slow moving” heparins, dermatan sulfate, and chondroitin sulfate: qualitative and quantitative analysis by agarose-gel electrophoresisCarbohydrate Research, 1993
- Degradation of Chondroitin 4-Sulfate by Rat Stomach Exoglycosidases, Sulfohydrolase and Hyaluronidase-Like EnzymesDigestion, 1981